Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-25-114915
Filing Date
2025-05-07
Accepted
2025-05-07 16:21:19
Documents
17
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d932107d10ka.htm   iXBRL 10-K/A 81335
2 EX-31.3 d932107dex313.htm EX-31.3 3386
3 EX-31.4 d932107dex314.htm EX-31.4 3419
  Complete submission text file 0001193125-25-114915.txt   315085

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA inab-20241231.xsd EX-101.SCH 4578
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inab-20241231_cal.xml EX-101.CAL 655
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inab-20241231_def.xml EX-101.DEF 17846
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE inab-20241231_lab.xml EX-101.LAB 24240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inab-20241231_pre.xml EX-101.PRE 19512
19 EXTRACTED XBRL INSTANCE DOCUMENT d932107d10ka_htm.xml XML 8312
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39692 | Film No.: 25921750
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)